NCT05372718

Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial

← Centro de ensayos clínicos

Campos del registro

Estado general: COMPLETED
Condiciones: Acute Limb Ischemia
Tipo de estudio: INTERVENTIONAL
Fase: PHASE3
Objetivo principal: TREATMENT
Tipo de intervención: DRUG, PROCEDURE
Intervenciones: Recombinant non-immunogenic staphylokinase (Fortelyzin®), surgical methods of treatment
Patrocinador principal: Supergene, LLC (INDUSTRY)

En caché: 2026-10-06 06:39:50

Ver en ClinicalTrials.gov

Resumen breve

Objective: to evaluate the efficacy and safety of intra-arterial intrathrombus administration of the recombinant non-immunogenic staphylokinase (Fortelyzin®) in patients with acute limb ischemia (ALI) vs surgery.

Contacto

¿Necesita un informe o redacción médica basada en este ensayo?

Solicitar un informe Redacción médica Informe de investigación a medida